ClinicalTrials.gov as a Source of Information About Expanded Access Programs: Cohort Study
BackgroundClinicalTrials.gov (CT.gov) is the most comprehensive internet-based register of different types of clinical studies. Expanded access is the use of unapproved drugs, biologics, or medical devices outside of clinical trials. One of the key problems in expanded access is the availability to...
Saved in:
Main Authors: | Jan Borysowski (Author), Andrzej Górski (Author) |
---|---|
Format: | Book |
Published: |
JMIR Publications,
2021-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Assessing the Impact of the NIH CTSA Program on Clinical Trials Registered With ClinicalTrials.gov
by: Arthur Berg
Published: (2020) -
Amphetamines in child medicine: a review of ClinicalTrials.gov
by: Samer O. Alalalmeh, et al.
Published: (2023) -
Comprehensive Survey of Clinical Trials Registration for Melanoma Immunotherapy in the ClinicalTrials.gov
by: Yan-Bo Wang, et al.
Published: (2020) -
Characteristics of endodontic clinical trials registered in clinicalTrials.gov between 2000 and 2022
by: Gadde Praveen, et al.
Published: (2023) -
Characterization of interventional clinical trials for monkeypox; systematic review of ClinicalTrials.gov database
by: Nasser M. Alorfi, et al.
Published: (2023)